Aimmune Therapeutics said Thursday the Food and Drug Administration's advisory committee on allergenic products will review its experimental peanut allergy pill in September, setting a date for an initial test of the growing allergy desensitization field.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,